Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy

2014231 citationsJournal Article

Authors

clinicaltrials.gov Identifier: NCT01793844; Chinese Clinical Trial Registry Identifier: CTR-TRC-11001687.

Good health and well-being

Published in: JAMA

Volume 312, Issue 23, pp. 2521-2521

Field-Weighted Citation Impact: 15.66